Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CPSR BATS:QTOC NYSEARCA:XIDE NYSEARCA:XMAY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPSRCapstar Special Purpose Acquisition$24.70+0.0%$8.28$6.06▼$12.23$852.15M0.07556,189 shs10,768 shsQTOCInnovator Growth Accelerated Plus ETF - October$33.10+4.9%$32.57$23.96▼$32.46$14.27M0.965,071 shs1,205 shsXIDEFT Cboe Vest U.S. Equity Buffer & Premium Income ETF - December$30.30+0.0%$30.30$27.98▼$30.76$22.12M0.145,937 shs49,285 shsXMAYFtvst Us Eqty Enh Md May$34.05+0.1%$33.66$29.09▼$34.05$22.13MN/A11,183 shs366 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPSRCapstar Special Purpose Acquisition+0.10%+0.25%+0.69%+2.45%+278.08%QTOCInnovator Growth Accelerated Plus ETF - October+0.10%+0.93%+1.04%+6.50%+19.21%XIDEFT Cboe Vest U.S. Equity Buffer & Premium Income ETF - December+0.03%+0.30%+0.13%+0.66%+0.20%XMAYFtvst Us Eqty Enh Md May+0.06%+0.56%+1.01%+3.72%+11.79%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPSRCapstar Special Purpose Acquisition$24.70+0.0%$8.28$6.06▼$12.23$852.15M0.07556,189 shs10,768 shsQTOCInnovator Growth Accelerated Plus ETF - October$33.10+4.9%$32.57$23.96▼$32.46$14.27M0.965,071 shs1,205 shsXIDEFT Cboe Vest U.S. Equity Buffer & Premium Income ETF - December$30.30+0.0%$30.30$27.98▼$30.76$22.12M0.145,937 shs49,285 shsXMAYFtvst Us Eqty Enh Md May$34.05+0.1%$33.66$29.09▼$34.05$22.13MN/A11,183 shs366 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPSRCapstar Special Purpose Acquisition+0.10%+0.25%+0.69%+2.45%+278.08%QTOCInnovator Growth Accelerated Plus ETF - October+0.10%+0.93%+1.04%+6.50%+19.21%XIDEFT Cboe Vest U.S. Equity Buffer & Premium Income ETF - December+0.03%+0.30%+0.13%+0.66%+0.20%XMAYFtvst Us Eqty Enh Md May+0.06%+0.56%+1.01%+3.72%+11.79%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCPSRCapstar Special Purpose Acquisition 0.00N/AN/AN/AQTOCInnovator Growth Accelerated Plus ETF - October 0.00N/AN/AN/AXIDEFT Cboe Vest U.S. Equity Buffer & Premium Income ETF - December 0.00N/AN/AN/AXMAYFtvst Us Eqty Enh Md May 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCPSRCapstar Special Purpose AcquisitionN/AN/AN/AN/A($1.18) per shareN/AQTOCInnovator Growth Accelerated Plus ETF - OctoberN/AN/AN/AN/AN/AN/AXIDEFT Cboe Vest U.S. Equity Buffer & Premium Income ETF - DecemberN/AN/AN/AN/AN/AN/AXMAYFtvst Us Eqty Enh Md MayN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCPSRCapstar Special Purpose Acquisition-$15.30MN/A0.00∞N/AN/AN/AN/AN/AQTOCInnovator Growth Accelerated Plus ETF - OctoberN/AN/A29.40∞N/AN/AN/AN/AN/AXIDEFT Cboe Vest U.S. Equity Buffer & Premium Income ETF - DecemberN/A-$2.89N/A∞N/AN/AN/AN/AN/AXMAYFtvst Us Eqty Enh Md MayN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCPSRCapstar Special Purpose AcquisitionN/AN/AN/AN/AN/AQTOCInnovator Growth Accelerated Plus ETF - OctoberN/AN/AN/AN/AN/AXIDEFT Cboe Vest U.S. Equity Buffer & Premium Income ETF - December$1.986.53%N/AN/A N/AXMAYFtvst Us Eqty Enh Md MayN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCPSRCapstar Special Purpose AcquisitionN/A0.130.13QTOCInnovator Growth Accelerated Plus ETF - OctoberN/AN/AN/AXIDEFT Cboe Vest U.S. Equity Buffer & Premium Income ETF - DecemberN/AN/AN/AXMAYFtvst Us Eqty Enh Md MayN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCPSRCapstar Special Purpose Acquisition64.87%QTOCInnovator Growth Accelerated Plus ETF - OctoberN/AXIDEFT Cboe Vest U.S. Equity Buffer & Premium Income ETF - December74.64%XMAYFtvst Us Eqty Enh Md MayN/AInsider OwnershipCompanyInsider OwnershipCPSRCapstar Special Purpose AcquisitionN/AQTOCInnovator Growth Accelerated Plus ETF - OctoberN/AXIDEFT Cboe Vest U.S. Equity Buffer & Premium Income ETF - December3.80%XMAYFtvst Us Eqty Enh Md MayN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCPSRCapstar Special Purpose Acquisition234.50 millionN/ANot OptionableQTOCInnovator Growth Accelerated Plus ETF - OctoberN/A450,000N/ANot OptionableXIDEFT Cboe Vest U.S. Equity Buffer & Premium Income ETF - DecemberN/A730,000N/AN/AXMAYFtvst Us Eqty Enh Md MayN/A650,000N/AN/AQTOC, CPSR, XMAY, and XIDE HeadlinesRecent News About These CompaniesThis Week in ETFs: Roster of 17 New ETFs Includes 6 Buffer FundsMay 24, 2024 | etftrends.comEQTOC, CPSR, XMAY, and XIDE Company DescriptionsCapstar Special Purpose Acquisition NYSE:CPSRCapstar Special Purpose Acquisition Corp. is a blank check company. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the consumer, healthcare, and technology, media and telecommunications industries. The company was incorporated in 2020 and is based Austin, Texas.Innovator Growth Accelerated Plus ETF - October BATS:QTOC$33.10 +1.55 (+4.92%) As of 09/9/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Innovator Growth Accelerated Plus ETF - October (QTOC) is an exchange-traded fund that is based on the Invesco QQQ Trust index. The fund aims for 3x the price return of Invesco QQQ Trust ETF (QQQ), subject to an upside return cap over a specific holdings period. QTOC was launched on Oct 1, 2021 and is managed by Innovator.FT Cboe Vest U.S. Equity Buffer & Premium Income ETF - December NYSEARCA:XIDE$30.30 +0.01 (+0.03%) As of 09/9/2025 04:10 PM EasternThe FT Vest U.S. Equity Buffer & Premium Income ETF - December (XIDE) is an exchange-traded fund that mostly invests in large cap equity. The fund seeks to provide a consistent income stream and a buffer against the first 10% of losses over a one-year period. The actively managed fund holds a package of SPY FLEX options and US Treasurys. XIDE was launched on Dec 15, 2023 and is issued by First Trust.Ftvst Us Eqty Enh Md May NYSEARCA:XMAY$34.05 +0.02 (+0.06%) As of 09/9/2025 04:10 PM EasternThe FT Vest U.S. Equity Enhance & Moderate Buffer ETF - May (XMAY) is an exchange-traded fund that mostly invests in large cap equity. The fund seeks to outperform the SPY ETF at about 2x positive price returns while aiming for specific buffered losses and capped gains over a one-year period. The actively managed fund holds options and collateral. XMAY was launched on May 17, 2024 and is issued by First Trust. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Should You Buy Figma Stock After Its 55% Post-IPO Drop? Ulta Beauty Stock: Strong Growth, Short-Term Volatility Ahead Joby's Stock Is Quiet, But a Storm of Catalysts Is Brewing The Quiet Before the Catalyst: Vertical Aerospace's Next Move Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver Insiders Sell These High-Quality Stocks: Why Investors Shouldn’t Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
